Renaissance Technologies (RenTech)'s TXG Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 1.55 M shares of 10x Genomics, Inc. (TXG) worth $25.29 M, representing 0.04% of the portfolio. First purchased in 2020-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TXG, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 782,700 shares. Largest reduction occurred in Q3 2025, reducing 427,334 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +505,618 | Add 48.39% | 1.55 M | $16.31 |
| Q3 2025 | -427,334 | Reduce 29.03% | 1.04 M | $11.69 |
| Q2 2025 | +782,700 | Add 113.51% | 1.47 M | $11.58 |
| Q1 2025 | +302,600 | Add 78.20% | 689,555 | $8.73 |
| Q4 2024 | +386,955 | New Buy | 386,955 | $14.36 |
| Q3 2024 | -210,200 | Sold Out | 0 | $0.00 |
| Q2 2024 | +157,800 | Add 301.15% | 210,200 | $19.45 |
| Q1 2024 | +52,400 | New Buy | 52,400 | $37.54 |
| Q2 2022 | -57,800 | Sold Out | 0 | $0.00 |
| Q1 2022 | +40,000 | Add 224.72% | 57,800 | $76.07 |
| Q4 2021 | -74,616 | Reduce 80.74% | 17,800 | $148.93 |
| Q3 2021 | +92,416 | New Buy | 92,416 | $145.58 |
| Q1 2021 | -162,700 | Sold Out | 0 | $0.00 |
| Q4 2020 | -133,400 | Reduce 45.05% | 162,700 | $141.60 |
| Q3 2020 | +6,464 | Add 2.23% | 296,100 | $124.68 |
| Q2 2020 | +279,100 | Add 2649.01% | 289,636 | $89.31 |
| Q1 2020 | +10,536 | New Buy | 10,536 | $62.36 |
Renaissance Technologies (RenTech)'s 10x Genomics Investment FAQs
Renaissance Technologies (RenTech) first purchased 10x Genomics, Inc. (TXG) in Q1 2020, acquiring 10,536 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held 10x Genomics, Inc. (TXG) for 17 quarters since Q1 2020.
Renaissance Technologies (RenTech)'s largest addition to 10x Genomics, Inc. (TXG) was in Q2 2025, adding 1,472,255 shares worth $17.05 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 1,550,539 shares of 10x Genomics, Inc. (TXG), valued at approximately $25.29 M.
As of the Q4 2025 filing, 10x Genomics, Inc. (TXG) represents approximately 0.04% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in 10x Genomics, Inc. (TXG) was 1,550,539 shares, as reported at the end of Q4 2025.